Northwestern Lake Forest Hospital
Lake Forest, Illinois 60045
0 studies enrolling now · 12 studies all time
What they study most
ADH Inappropriate, Adult Anaplastic Astrocytoma, Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Astrocytoma, Breast Carcinoma Metastatic in the Brain, Diffuse Large B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma Activated B-Cell Type, Diffuse Large B-Cell Lymphoma Germinal Center B-Cell Type, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
Studies at this site
- The Efficacy of a Novel, Non-contact EKG in the NICU — Stopped early
- Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma — Running, not enrolling
- Combination Chemotherapy and TAK-659 as Front-Line Treatment in Treating Patients With High-Risk Diffuse Large B Cell Lymphoma — Completed
- Guadecitabine and Pembrolizumab in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer — Completed
- Comparative Study of the ANNE™ One System to Diagnose Obstructive Sleep Apnea — Completed
- SOFI: A Quality Improvement Project to Standardize Use of Intravenous Fluids in Hospitalized Pediatric Patients — Completed
- Effectiveness of Point of Care Complete Blood Cell Count Analyzer in Reducing Time to Results — Status unconfirmed
- Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19) — APPROVED_FOR_MARKETING
- Pembrolizumab and Capecitabine in Treating Patients With Locally Advanced or Metastatic Triple Negative or Hormone-Refractory Breast Cancer That Cannot Be Removed by Surgery — Status unconfirmed
- Palbociclib in Treating Patients With Metastatic HER-2 Positive Breast Cancer With Brain Metastasis — Stopped early
- Efficacy of Hypofractionated XRT w/Bev. + Temozolomide for Recurrent Gliomas — Stopped early
- Evaluation of the Impact of Germicidal Light (Indigo-Clean) on Intraoperative S. Aureus Exposure — Status unconfirmed